Aligos Therapeutics, Inc 10-K for FY2024
Aligos Therapeutics, Inc. (ALGS)
10-K
2025-03-10
For: 2024-12-31
View Original
Added on
April 11, 2026
About this 10-K
Aligos Therapeutics, Inc filed this 10-K on March 10, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.61M
- down 41.7% from $6.19M a year earlier
- Net loss
- $131.21M
- compared with a net loss of $87.68M a year earlier
- Diluted EPS
- -$20.94
- compared with -$34.20 a year earlier